Investorideas.com newswire, breaking news for marijuana, cannabis and hemp stocks

Monday, 8 April 2019

#California #Cannabis Distribution Deals Bring Good News to California Market; (CSE: $EAT.C) (CSE: $OH.C) (CSE: $GRIN.C) (CSE: $GABY.C)



#California #Cannabis Distribution Deals Bring Good News to California Market; (CSE: $EAT.C) (CSE: $OH.C) (CSE: $GRIN.C) (CSE: $GABY.C)



Point Roberts WA, Delta BC – April 8, 2019 - Investorideas.com, a leading investor news resource covering hemp and cannabis stocks releases a market snapshot discussing the success of recent distribution agreements in the California cannabis space.

Nutritional High International Inc. (CSE: EAT) (OTCQB: SPLIF), a company focused on developing, manufacturing and distributing products under recognized brands in the cannabis products industry, with a specific focus on edibles and oil extracts for medical and adult recreational use, recently congratulated Cresco Labs Inc. on their agreement to acquire Origin House.








"We are pleased that another California distribution and manufacturing company with many similarities was acquired at such a healthy multiple," commented Adam Szweras, Co-Chair of the Nutritional High board. "This acquisition and the valuation of Origin House are a vote of confidence for companies like Nutritional High, signaling that the market values companies who are able to control shelf space and realize greater margins and market penetration through ownership of the distribution pipeline."

Nutritional High recently released their Q2 2019 Financials with some of the highlights of $6.1 million from the sale of Cannabis related products in California, primarily via its wholly owned distributor, Calyx Brands Inc. which represents an annualized revenue run rate of $24.2 million.
At the end of January 31, 2019, the Company has now recognized a trailing twelve-month revenue from Cannabis sales of approximately $17.6 million, making Nutritional High's Calyx now one of the largest distributors in California.

Cresco Labs Inc. and CannaRoyalty Corp., d/b/a Origin House (CSE: OH) (OTCQX: ORHOF) recently announced that they have entered into a definitive agreement in which Cresco Labs will acquire all of the issued and outstanding shares of Origin House, representing a total consideration of approximately C$1.1 billion on a fully-diluted basis, or C$12.68 per Origin House Share.

The Transaction represents the largest public company acquisition in the history of the US cannabis industry. The combined entity will be: one of the largest vertically-integrated multi-state cannabis operators in the United States; a leading North American cannabis company, by footprint; and one of the largest cannabis brand distributors.

Grown Rogue International Inc. (CSE:GRIN) (OTC: NVSIF), a vertically-integrated, multi-state cannabis company with licenses and operations in Oregon, California, and now Michigan recently released its financial and operating results for the three months ended January 31, 2019.

Some of the first Quarter 2019 highlights included: a first quarter revenue growth of 388% year-over-year to $834,309 which is expected to continue as the Company proceeds with its expansion plans in Oregon, California and Michigan, gross margin improved to 31% compared to negative gross margin Q1-2018, and Grown Rogue products in over 220 dispensaries in Oregon.

"Our Fiscal 2019 Q1 represents the first full quarter for Grown Rogue as a public company and marks the Company's 5th consecutive quarter of revenue growth since launching first in the state of Oregon in late 2017," said Obie Strickler, President and CEO of Grown Rogue. "To have gained this brand recognition and sales traction, in what is arguably the world's most competitive legalized cannabis market, bodes very well for our expansion into California and particularly the newly legalized market in Michigan. We've grown very quickly from controlling just 3 licenses in one state a year ago to assets allowing us to have 22 licenses in three states today."

Gabriella's Kitchen Inc. (CSE: GABY), an innovative and leading-edge cannabis wellness company is ensuring its own distribution throughout the state having recently announced the completion of its acquisition of all of the issued and outstanding shares of Sonoma Pacific Distribution, Inc., California's premier, independently-owned cannabis distribution company, which was previously announced on October 23, 2018.  With the closing of the Acquisition, GABY gains an expansive distribution reach across the state of California, which currently represents the world's most thriving cannabis market as well as a permanent cannabis distribution license that was issued to Sonoma Pacific by the California Bureau of Cannabis Control and the County of Santa Rosa on March 14, 2019.

"With the support of GABY and its executive team as well as the ability to leverage GABY's infrastructure, Sonoma Pac realized a record-breaking first quarter of 2019.  For the three month period ending March 31, 2019, it is estimated that Sonoma Pac generated revenue that exceeds CDN$8 Million from the sale of our proprietary products," stated Aaron Browe, President of Sonoma Pac.  "That number represents a massive 1,200% increase over the same quarter last year."

As California is currently the world’s largest regulated cannabis market, the market trends and developments that occur there will have a large impact on how the rest of the cannabis industry operates. These recent developments show that strong financials and a solid distribution channel have become necessities in this maturing market.

The California Senate voted last Thursday, April 4th (voting 32-4), passing a bill that would allow the state to extend temporary licenses to cultivators until replacements are approved, removing a potentially large obstacle and showing it wants to maintain its market share.    

For investors following cannabis stocks, Investor Ideas has created a stock directory of publicly traded CSE, TSX, TSXV, OTC, NASDAQ, NYSE, ASX Marijuana/Hemp Stocks

About Investorideas.com
Investorideas.com is a recognized news source publishing third party news and press releases plus we create original financial content. Learn about investing in stocks and  sector trends  from Investorideas.com with our news alerts , articles , podcasts and videos  talking about cannabis,  crypto,  technology including  AI and IoT , mining ,sports biotech, water, renewable energy and more . Investorideas.com original branded content includes the daily Crypto Corner and Podcast, Play by Play sports and stock news column, Investor Ideas #Potcasts #Cannabis News and Stocks on the Move podcast and column,  Cleantech and Climate Change Podcast and  the AI Eye Podcast and column covering developments in AI. 

Follow us on Cannabis Social Media

Disclaimer/Disclosure:. Our site does not make recommendations for purchases or sale of stocks, services or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investment involves risk and possible loss of investment. This site is currently compensated for news publication and distribution, social media and marketing, content creation and more. Contact each company directly regarding content and press release questions. Disclosure is posted for each compensated news release, content published /created if required but otherwise the news was not compensated for and was published for the sole interest of our readers and followers. More disclaimer info: https://www.investorideas.com/About/Disclaimer.asp. Disclosure: this article featuring Nutritional High International Inc. (CSE: EAT) (OTC: SPLIF) is a paid for service on Investorideas.com.  Learn more about costs and our services https://www.investorideas.com/News-Upload/
Global Investors must adhere to regulations of each country.

Investor Ideas does not condone the use of cannabis except where permissible by law. Our site does not possess, distribute, or sell cannabis products.

Please read Investorideas.com privacy policy: https://www.investorideas.com/About/Private_Policy.asp


Contact Investorideas.com
800-665-0411

The Willows Farms Has been Awarded Conditional Approval for Five Cannabis Licenses



The Willows Farms Has been Awarded Conditional Approval for Five Cannabis Licenses



Montego Bay, Jamaica – The Willows Farms Limited recently received a green light to start business, as they were awarded their conditional approval for five licenses from the Cannabis Licensing Authority.  The company is on a mission to help diversify Jamaica’s economic base. Jamaica is set to emerge as an indigenous leader in the medical cannabis space. Consequently, the country is perfectly positioned with a spotlight on producing safe and effective high-grade strains for future exports worldwide. 

Due to the international expansion of medicinal cannabis, The Willows Farms welcomes the opportunity to introduce our initiative to strategic partners. The objective is to forge an alliance of integrity that supports a systemic framework to diversify wellness.  This benefit is certain to enable monetization opportunities within branding license, land segments, and community infrastructure.


“We’re thrilled to be part of a select group of businesses who can participate in the early-stages of the legal medical cannabis market in Jamaica,” said Monique Drayton, the Director of Communications for The Willows Farms.  While Jamaica has been known for many cultural sentiments, its ideal atmospheric conditions are prime for this agricultural pursuit.

The Cannabis Licensing Authority issued
The Willows Farms the following licenses:

* Cultivator’s License (Tier 3) (Over 5 acres)
* Processing License (Tier2) (> 200 sq. meters)
* Research & Development (Experimental) License
* Retail (Herb House – Without Facilities for Consumption) License
* Transport License

“The Cultivator’s License Tier 3 is particularly important, because we have over 500 acres of land that we’ve earmarked to use in the development with a significant portion being dedicated to grow medical cannabis. We’re actively seeking experienced partners who are ready to harness this seismic venture right away,” added Monique Drayton. The Willows Farms plans to serve various purposes for educational opportunities, economic growth with a sustainable trading base, and strategic wellness training programs conducive to safe learning environments. 

Despite the number of competitors entering the cannabis market, The Willows Farms is appropriately positioned to be a premier producer. The strength of Jamaica’s tourism market, through historical intention and interest, has been the conduit of successfully attracting attention to produce high grade cannabis strains. As a result, The Willows Farms is excited to support this health & wellness endeavor byway of adding a strong presence to Jamaica’s already culturally rich community.  

The Willows Farms has assembled a network team of qualified professionals and invaluable resources. This therapeutic business model has been strategically designed to collaborate with universities to generate optimal opportunities for students interested in pursuing the cannabis industry’s research and development process. With the conditional approval and usable land space, The Willows Farms is currently making provisions to start operations in this rapidly evolving market. The legalization of medical cannabis has provided an unprecedented platform for licensed cannabis businesses to finally reach previously underserved, prescribed patients. With that, the fundamental goal is to successfully establish a credible, international brand focused on creating new jobs to facilitate financial freedom for the systemic roots of Jamaica.

Contact
The Willows Farms Limited
Representative
hello@thewillowsfarms.com
P: 305-537-6597
www.thewillowsfarms.com


About The Willows Farms Limited:
The Willows Farms is proud to be a conditionally approved medical cannabis cultivator, processor, transporter, research & developer, and retailer.

We are committed to producing a high quality product with valued integrity cultivated by local farmers and grown in the most natural, tropical atmosphere. Moreover, we strive to ensure that it is available to prescribed patients who are in need of accessible and affordable medical cannabis. Our strengths run through our bloodline to help drive research and innovation, create jobs across the island, and bring international investments that will fuel the growth and development of the economy.

This news is published on the Investorideas.com Newswire – News that Inspires big ideas
Disclaimer/Disclosure: Investorideas.com is a digital publisher of third party sourced news, articles and equity research as well as creates original content, including video, interviews and articles. Original content created by investorideas is protected by copyright laws other than syndication rights. Our site does not make recommendations for purchases or sale of stocks, services or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investment involves risk and possible loss of investment. This site is currently compensated for news publication and distribution, social media and marketing, content creation and more. Contact each company directly regarding content and press release questions. Disclosure is posted for each compensated news release, content published /created if required but otherwise the news was not compensated for and was published for the sole interest of our readers and followers. More disclaimer info: http://www.investorideas.com/About/Disclaimer.asp. Disclosure this news is a paid for news release on the Investorideas.com newswire by The Willows Farms Limited Learn more about costs and our newswire service https://www.investorideas.com/News-Upload/
Global investors must adhere to regulations of each country.

Investor Ideas does not condone the use of cannabis except where permissible by law. Our site does not possess, distribute, or sell cannabis products.

Please read Investorideas.com privacy policy: https://www.investorideas.com/About/Private_Policy.asp



Friday, 5 April 2019

Investorideas.com - Cannabis News: SOL Global to Spin Off Cannabinoid Drug Therapy Research and Development Subsidiary

Investorideas.com - Cannabis News: SOL Global to Spin Off Cannabinoid Drug Therapy Research and Development Subsidiary

Investorideas.com - Cannabis News: Aphria (NYSE: APHA) Awarded Provisional Approval in Germany for Cannabis Cultivation License

Investorideas.com - Cannabis News: Aphria (NYSE: APHA) Awarded Provisional Approval in Germany for Cannabis Cultivation License

Investor Ideas #Potcasts, #Cannabis News and Stocks on the Move: (CSE: $DIXI_U.C), (CSE: $SNN.C), (TSX: $ACB.TO) (NYSE: $ACB), (TSX: $APHA.TO) (NYSE: $APHA), (CSE: $SOL.C)



Investor Ideas #Potcasts, #Cannabis News and Stocks on the Move:  (CSE: $DIXI_U.C), (CSE: $SNN.C), (TSX: $ACB.TO) (NYSE: $ACB), (TSX: $APHA.TO) (NYSE: $APHA), (CSE: $SOL.C)



Delta, Kelowna, BC –April 5th, 2019 (Investorideas.com Newswire) www.Investorideas.com, a global news source covering leading sectors including marijuana and hemp stocks and its potcast site, www.potcasts.ca  release today’s edition of Investorideas.com potcastsCM - cannabis news and stocks to watch plus insights from thought leaders and experts.

Listen to the podcast:



Today’s podcast overview/transcript:

Good afternoon and welcome to another Investorideas.com “potcast” looking at cannabis news, stocks to watch as well as insights from experts and industry leaders.

Today we are looking at announcements from Dixie Brands Inc, Sunniva Inc, Aurora Cannabis Inc. Aphria Inc. and SOL Global Investments Corp.

Dixie Brands Inc.  (CSE: DIXI.U), (OTC: DXBRF), one of the cannabis industry's leading consumer packaged goods (CPG) companies, has announced plans to introduce a new confectionary product called Dixie Bursts™. The pulled taffy chews will be sold in assorted packages containing Blue Raspberry, Mango and Strawberry flavors. Each individually-wrapped Burst will contain 10 milligrams of THC.

"Dixie has been crafting quality infused-cannabis products for nearly a decade and is constantly seeking new ways to satisfy the evolving needs of our consumers who love to explore new flavors and formats," said Andrew Floor, Dixie's Vice President of Marketing. "We've had a phenomenal reaction to our latest innovation, Dixie Bursts, a hand-pulled taffy which is absolutely bursting with flavor and has a softer texture than the few comparable products in the market today."
         
Edibles are gaining popularity in jurisdictions where cannabis use is permitted, with sales growth rates outpacing those of dried flower. For example, according to BDS Analytics data for January 2019 in Colorado, one of the most mature cannabis markets in the U.S., sales of both flower and pre-rolled joints declined from one year earlier and now represent less than half of total sales.  Sales of ingestibles in the state increased by 17% over the same period, with the candy sub-category growing by 25%.


Sunniva Inc. (CSE: SNN) (OTCQB: SNNVF), a North American provider of cannabis products and services, announced preliminary revenue of $14.0 million for the three month period ended March 31, 2019.  This represents a 169% increase over the $5.2 million in revenue generated in the comparative three-month period from 2018.

In California, Sunniva began selling cannabis products in the first three months of 2019 through its wholly-owned subsidiary, CP Logistics, LLC with preliminary revenue of $10.0 million (USD $7.5 million). Revenue was comprised of product sales from premium flower, vape cartridges and concentrates. In March, Sunniva unveiled its first three in-house brands, Sun Fire, KYNDNESS and Herbella, and announced that additional super premium brands will be launched in conjunction with production from the 325,000 sq. ft. purpose-built greenhouse under construction in Cathedral City, California.

The Company's other wholly owned subsidiaries, Full-Scale Distributors, LLC and Natural Health Services Ltd., contributed first quarter 2019 revenue of $2.3 million and $1.7 million, respectively.

"In California, we now have the strategic pillars in place to ensure scalability and growth for our newly announced brands and we are very proud of our entire team for the execution and delivery of a very strong first quarter," said Dr. Anthony Holler, CEO of Sunniva. "Our $14.0 million in revenue during the first quarter is close to the total revenue generated by Sunniva in all of 2018. With strong leadership and operating assets producing premium cannabis products, supported by our recent distribution company acquisition, we continue to demonstrate our ability to achieve significant revenue growth and secure shelf space for our Sunniva brands throughout the state."

Aurora Cannabis Inc. (TSX: ACB) (NYSE: ACB), announced today that the Company has been selected by the German Bundesinstitut für Arzneimittel und Medizinprodukte BfArM (Federal Institute for Drugs and Medical Devices) as one of three winners in the public tender to cultivate and distribute medical cannabis in Germany. The contract will be formalized at the earliest on April 17, 2019, pending the outcome of an appeal procedure on which a ruling is anticipated by April 10, 2019.

The tender saw 79 companies participating,  with the winners able to establish production in Germany upon the completion of the contract associated with the tender. The selection process was based on the submission of a concept for domestic cannabis production, delivery and pricing. Aurora's concept, judged on criteria such as facility design, quality, security and logistics, received the highest ranking out of all concepts submitted, validating the Company's leadership in integrated cultivation, production and delivery.
The Company was awarded the maximum number of 5 of the 13 lots in the tender over a period of four years with a minimum supply of 4000kg total. The cannabis produced will be sold to the German government and supplied to wholesalers for distribution to pharmacies.

Aphria Inc. (TSX: APHA) (NYSE: APHA  is also entering the German market having announced that its German subsidiary Aphria Deutschland GmbH has been selected by the German Federal Institute for Drugs and Medical Devices ("BfArM") to receive a license for the domestic cultivation of medical cannabis. The provisional decision announced by BfArM is subject to a mandatory 10-day standstill period for public contracts, which permits unsuccessful bidders to challenge the decision before the final contract is signed. BfArM's decision would grant Aphria 5 of the 13 available lots, each with a minimum annual capacity of 200 kg.

"Aphria is proud to have been selected as a successful applicant in the German tender process, a testament to our high production quality standards," said Hendrik Knopp, Managing Director of Aphria Germany. "The decision from BfArM is a validation of our strategic approach to supporting the German medical cannabis market, including with high-quality, domestic production to secure vital supply for patients. We are very pleased with our continued business momentum in Germany."

SOL Global Investments Corp. (CSE:SOL) (OTCQB:SOLCF),  announced that it intends to spin off its wholly-owned subsidiary, Scythian Biosciences Inc. ("SBI"), into an independent, publicly-traded company. Upon closing of the Spin-off, which is expected to occur on or before September 30, 2019, SOL shareholders will own shares of both companies.

In connection with the Spin-off, SBI will be renamed "Impact Biosciences Corp" ("Impact") and will continue to pursue a drug development in the United States for the treatment of concussions and traumatic brain injury with its proprietary Cannabinoid combination drug candidate, which is being developed under contract with the University of Miami. Impact's mission is to become the first accepted drug regimen for concussive treatment. Impact has a collaboration with the University of Miami and its world-renowned neuroscientific team to conduct pre-clinical and clinical trials of its drug regimen.

Impact's Traumatic Brain Injury (TBI) Combination Therapy is currently in the pre-clinical research phase and is undergoing animal testing. Upon completion of this pre-clinical phase and applicable IND enabling studies, Impact will prepare and file an investigational new drug ("IND") application with the FDA, which, if granted, would permit Impact to begin human testing. Impact has applied for two patents related to its TBI treatment strategy, involving the combination of multiple chemical pathways into a therapeutic regimen targeted at reducing post-injury inflammation and inhibiting the resultant gliosis and the immune cascade. Impact has found a unique way to apply several pre-existing drugs in a way not previously done to target these processes.

Investor ideas reminds all listeners to read our disclaimers and disclosures on the
Investorideas.com  website and this podcast is not an endorsement to buy products or services or securities. Investors are reminded all investment involves risk and possible loss of investment   


Subscribe to the new cannabis podcast series:


To hear more Investorideas.com podcasts visit: https://www.investorideas.com/Audio/.

Investorideas.com podcasts are also available on iTunes,  Spotify, Google Play Music, Stitcher, Spreaker,   YouTube via Spreaker,  iHeartradio and Tunein.

Potcasts is now a certified word mark Trademark on the blockchain through Cognate, Inc. CM Certification-Registration Number: 10468217708

Get the cannabis/hemp stock directory as an Investor ideas member , plus get weekly updates with new pot stocks added and get the daily potcast for Investor Ideas #Potcasts #Cannabis News and Stocks on the Move.  Learn more https://www.investorideas.com/membership/




About Investorideas.com - News that Inspires Big Investing Ideas
Investorideas.com is a recognized news source publishing third party news and press releases plus we create original financial content. Learn about investing in stocks and  sector trends  from Investorideas.com with our news alerts , articles , podcasts and videos  talking about cannabis,  crypto,  technology including  AI and IoT , mining ,sports biotech, water, renewable energy and more . Investorideas.com original branded content includes the daily Crypto Corner and Podcast, Play by Play sports and stock news column, Investor Ideas #Potcasts #Cannabis News and Stocks on the Move podcast and column,  Cleantech and Climate Change Podcast and  the AI Eye Podcast and column covering developments in AI. 

Disclaimer/Disclosure: Investorideas.com is a digital publisher of third party sourced news, articles and equity research as well as creates original content, including video, interviews and articles. Original content created by investorideas is protected by copyright laws other than syndication rights. Our site does not make recommendations for purchases or sale of stocks, services or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investment involves risk and possible loss of investment. This site is currently compensated for news publication and distribution, social media and marketing, content creation and more. Contact each company directly regarding content and press release questions. Disclosure is posted for each compensated news release, content published /created if required but otherwise the news was not compensated for and was published for the sole interest of our readers and followers.
Learn more about Investor ideas podcast and news publication  services and costs https://www.investorideas.com/News-Upload/ 
Global investors must adhere to regulations of each country.

Please read Investorideas.com privacy policy: https://www.investorideas.com/About/Private_Policy.asp

Investor Ideas does not condone the use of cannabis except where permissible by law. Our site does not possess, distribute, or sell cannabis products.


Follow us on Social Media

Contact Investorideas.com
800-665-0411



Public Support for Legalization Remains Strong, Despite Narrow Shortcomings in Challenging State Elections

Public Support for Legalization Remains Strong, Despite Narrow Shortcomings in Challenging State Elections : Public Support for Legalization...